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connote negative stereotypes about aging, their use runs the risk
of adversely affecting the individuals geriatricians dedicate their
careers to serving. But what does it say about the world we live
in that words describing age have become pejoratives?
Language transforms, evolves, and provides insight into
cultural values. Today, the word senile is replete with deroga-
tory connotations. Yet, it derives from the Latin senex, old
man, the same root word that senatus, or senate, comes from.
In ancient Rome, the words connoting old age and political
leadership tangled together and the honor of speaking ﬁrst in
the Roman Senate went to the oldest member. Similarly, the
governing body of ancient Sparta was called the Gerousia,
from the Greek word geros, or “old man.” Such words were
not always discriminatory. Once, they were marks of honor.
A story recounted in the Babylonian Talmud (tractate
Berakhot, folios 27b-28a), a text that was transcribed in ﬁrst-
century Judea, vividly illustrates a perspective on aging that is no
longer normative in the modernWestern world. The story begins
with a quote: “Rabbi Elazar ben Azariah said, behold I am like a
man of seventy years, and yet I never understoodwhy the story of
the Exodus fromEgypt be told at night.”Why, the Talmudic text
then asks, does Rabbi Elazar ben Azariah describe himself as like
amanof 70years?Either he is 70 years oldor he is not!
The text continues: Elazar ben Azariah was a renowned
scholar of ﬁrst-century Judea, appointed by the sages of his com-
munity to be the head of the High Court when he was only
18 years old. Qualiﬁed for leadership by character and learning,
he nevertheless feared that his young age would present an
obstacle to assuming his new role. He, therefore, prayed that he
be granted the appearance of an old man and thereby win the
trust and respect of his community. His prayers, the Talmud
relates, were answered and his hair turned white overnight, thus
rendering him “like aman of seventy years.”
In ﬁrst-century Judea, the physical markers of old age were
sought after and valued, even prayed for. Twenty-ﬁrst century
America venerates youth. Our society has given rise to a multi-
billion-dollar antiaging industry. One has only to open a maga-
zine, scroll through an Instagram feed, or drive on a highway to
encounter an onslaught of images advertising products promis-
ing to darken white hair, erase wrinkles, and restore youth. This
cultural aversion to old age extends beyond the aesthetic. As ger-
iatricians, we listen to our patients and learn about the experi-
ence of having one’s hearing loss conﬂated with cognitive
impairment, of being handed pages of instructions written in
print too small to decipher, and of watching a clinician talk to
one’s children about one’s healthcare plan, as if the person to
whom the plan ismost relevant is not even in the room.
Words matter. And because we live in a world that ideal-
izes youth, words connoting age have acquired demeaning and
potentially discriminatory connotations. These connotations
have inﬁltrated our vernacular to such an extent that “elderly”
is no longer an acceptable word in the geriatrics community.
Yet, while the modern world has become exceptionally skilled
in extending the human lifespan, the ancient world knew how
to value old age. It is the value of lessons learned, wisdom
acquired, and a life lived.
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FROM FRAILTY TO GERASTENIA
To the Editor: A group of experts organized by the
National Institute on Aging Intramural Research Program
and the Johns Hopkins Older Americans Independence
Center identiﬁed current barriers for the implementation of
frailty concepts into clinical practice.1 The ﬁrst of their ﬁve
major points was that the broad use of the generic term
“frailty” confuses clinicians and investigators and more spe-
ciﬁc language is needed.
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According to the Oxford Dictionary, the English term
frailty refers to a situation of being weak and delicate. Dur-
ing the 2000s, frailty has begun to describe a clinical
condition—a geriatric syndrome—where an individual is
exceptionally vulnerable to external and internal stressors.2
However, the term as such is weak and vague. Patients may
even feel the term to have a pejorative meaning.3 Maybe
not unexpectedly, because—again, according to the Oxford
Dictionary—frailty also refers to weakness in character or
morals! In non-English languages—like Swedish and
Finnish—we have also met with difﬁculties how to translate
the term, because “Anglisms” are generally avoided and
direct translations are clumsy and unspeciﬁc.
Even in modern medicine, terms derived from antique
Greek and Latin are universally accepted, with common
examples being diabetes, dementia, osteoporosis, sar-
copenia, and anesthesia. Accordingly, we have formulated
the term “gerastenia” as a translation of frailty, and this
term is gradually gaining acceptance in Finland and Sweden
(in the former, also ofﬁcially approved by the Board of
Medical Language). The word probably has a neutral tone
to patients, and we have aimed to use it to mean speciﬁcally
the phenotypic frailty,2 in geriatrics an accepted clinical
condition, which we anticipate to be better deﬁned in bio-
logical terms in the future.
We acknowledge that the word frailty has been used for
years in English medical language and changing it will likely
meet with resistance (especially when suggested by non-
English speakers). However, as shown by recent reviews,1,3
problems with the current term exist and this fragile rose
deserves a better name. Therefore, we dare make the follow-
ing suggestion: Gerastenia would mean a deﬁned clinical syn-
drome and phenotype that is an expression of the lack of
adaptive capacity of the organism,4 and that can be diag-
nosed with prevalences comparable to diabetes among indi-
viduals aged 70 years and older.
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REPLY TO FROM FRAILTY TO GERASTENIA
To the Editor: In response to the letter from Strandberg and
colleagues,1 we agree wholeheartedly that the term “frailty”
alone is not sufﬁcient to capture the speciﬁcity of the age-
related, deeply biological condition observed by many provid-
ing medical care to older adults. The recommendation to use
the term “physical frailty” in the previously published article is
a ﬁrst step toward the development of more speciﬁc terminol-
ogy for this condition. Indeed, we envision that using “physical
frailty” moving forward is only a ﬁrst step in the evolution of
terminology that will help patients and providers better
understand the condition.2
A good example of such evolutionary naming of a com-
mon syndrome is “dropsy,” a term commonly used in England
in the 17th century to describe leg swelling and shortness of
breath. Derived from the middle English dropesie and old
French hydropsie, the origin is thought to be from ancient
Greek hydrops and ultimately “hydro,” which means water.
As improved understanding of the pathophysiology at the
basis of dropsy-related shortness of breath and leg swelling
evolved, congestive heart failure came to be the more speciﬁc
way to describe the observed syndrome and the etiology of the
underlying signs and symptoms.
Although “gerastenia” certainly provides a more speciﬁc
name that could replace frailty, we believe a term that better
captures the biology that drives physical frailty in older
adults would be a preferable and more speciﬁc solution.
Given that the understanding of the biology of aging and its
inﬂuence on clinical phenotypes and disease states is rapidly
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